Effect of opioid peptides on dopamine release from nucleus accumbens after repeated treatment with methamphetamine. 1994

H Yokoo, and S Yamada, and M Yoshida, and T Tanaka, and K Mizoguchi, and H Emoto, and C Koga, and H Ishii, and M Ishikawa, and N Kurasaki
Department of Pharmacology, Kurume University School of Medicine, Japan.

The effect of opioid peptides on extracellular dopamine levels in the nucleus accumbens was compared between rats treated with methamphetamine and saline repeatedly (for 9 days) by using microdialysis. After the period of repeated treatment, the rats in both groups were kept for an additional 9 days without further treatment. Repeated administration of methamphetamine reduced the decreasing effect of dynorphin (10 microM), applied locally in the perfusate, and enhanced the increasing effect of [D-Ala2,MePhe4,Gly-ol5]enkephalin (DAGO, 10 microM) on the extracellular dopamine levels in the nucleus accumbens. It is possible that repeated treatment with methamphetamine leads to attenuation of the inhibition and enhancement of the stimulation of dopamine release from the nucleus accumbens via presynaptic dynorphin- and enkephalin-sensitive receptors, respectively.

UI MeSH Term Description Entries
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D008297 Male Males
D009714 Nucleus Accumbens Collection of pleomorphic cells in the caudal part of the anterior horn of the LATERAL VENTRICLE, in the region of the OLFACTORY TUBERCLE, lying between the head of the CAUDATE NUCLEUS and the ANTERIOR PERFORATED SUBSTANCE. It is part of the so-called VENTRAL STRIATUM, a composite structure considered part of the BASAL GANGLIA. Accumbens Nucleus,Nucleus Accumbens Septi,Accumbens Septi, Nucleus,Accumbens Septus, Nucleus,Accumbens, Nucleus,Nucleus Accumbens Septus,Nucleus, Accumbens,Septi, Nucleus Accumbens,Septus, Nucleus Accumbens
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D004399 Dynorphins A class of opioid peptides including dynorphin A, dynorphin B, and smaller fragments of these peptides. Dynorphins prefer kappa-opioid receptors (RECEPTORS, OPIOID, KAPPA) and have been shown to play a role as central nervous system transmitters. Dynorphin,Dynorphin (1-17),Dynorphin A,Dynorphin A (1-17)
D004745 Enkephalins One of the three major families of endogenous opioid peptides. The enkephalins are pentapeptides that are widespread in the central and peripheral nervous systems and in the adrenal medulla. Enkephalin
D000700 Analgesics Compounds capable of relieving pain without the loss of CONSCIOUSNESS. Analgesic,Anodynes,Antinociceptive Agents,Analgesic Agents,Analgesic Drugs,Agents, Analgesic,Agents, Antinociceptive,Drugs, Analgesic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D017551 Microdialysis A technique for measuring extracellular concentrations of substances in tissues, usually in vivo, by means of a small probe equipped with a semipermeable membrane. Substances may also be introduced into the extracellular space through the membrane.

Related Publications

H Yokoo, and S Yamada, and M Yoshida, and T Tanaka, and K Mizoguchi, and H Emoto, and C Koga, and H Ishii, and M Ishikawa, and N Kurasaki
October 1996, Annals of the New York Academy of Sciences,
H Yokoo, and S Yamada, and M Yoshida, and T Tanaka, and K Mizoguchi, and H Emoto, and C Koga, and H Ishii, and M Ishikawa, and N Kurasaki
November 1990, Journal of neurochemistry,
H Yokoo, and S Yamada, and M Yoshida, and T Tanaka, and K Mizoguchi, and H Emoto, and C Koga, and H Ishii, and M Ishikawa, and N Kurasaki
January 1989, The Journal of physiology,
H Yokoo, and S Yamada, and M Yoshida, and T Tanaka, and K Mizoguchi, and H Emoto, and C Koga, and H Ishii, and M Ishikawa, and N Kurasaki
May 2020, Psychopharmacology,
H Yokoo, and S Yamada, and M Yoshida, and T Tanaka, and K Mizoguchi, and H Emoto, and C Koga, and H Ishii, and M Ishikawa, and N Kurasaki
April 1994, Brain research,
H Yokoo, and S Yamada, and M Yoshida, and T Tanaka, and K Mizoguchi, and H Emoto, and C Koga, and H Ishii, and M Ishikawa, and N Kurasaki
November 1987, Brain research,
H Yokoo, and S Yamada, and M Yoshida, and T Tanaka, and K Mizoguchi, and H Emoto, and C Koga, and H Ishii, and M Ishikawa, and N Kurasaki
May 1985, Brain research,
H Yokoo, and S Yamada, and M Yoshida, and T Tanaka, and K Mizoguchi, and H Emoto, and C Koga, and H Ishii, and M Ishikawa, and N Kurasaki
January 2021, Frontiers in neuroscience,
H Yokoo, and S Yamada, and M Yoshida, and T Tanaka, and K Mizoguchi, and H Emoto, and C Koga, and H Ishii, and M Ishikawa, and N Kurasaki
May 2018, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
H Yokoo, and S Yamada, and M Yoshida, and T Tanaka, and K Mizoguchi, and H Emoto, and C Koga, and H Ishii, and M Ishikawa, and N Kurasaki
February 1998, Brain research,
Copied contents to your clipboard!